KTP - Target Healthcare Limited. Development of platform capability and creation of a robust framework for the assessment of shelf life and stability of a range of aseptically prepared Monoclonal Anti-Bodies (MABs) for patient use.

Project: Research

Project Details

StatusActive
Effective start/end date24/10/2223/10/24

Funding

  • Target Healthcare Limited
  • Innovate UK: £98,393.00